Covid-19: What do we know about Sputnik V and other Russian vaccines?-Reference-Cited by-同舟云学术

Covid-19: What do we know about Sputnik V and other Russian vaccines?

Published:2021-03-19 Issue: Volume: Page:n743
ISSN:1756-1833
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Baraniuk Chris

Publisher

BMJ

Subject

General Engineering

Reference23 articles.

1. King A . Vector-based vaccines come to the fore in the covid-19 pandemic. Scientist 2020. www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915.

2. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

3. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

4. Bucci E. Note of concern. Cattivi Scienziati. September 2020. https://cattiviscienziati.com/2020/09/07/note-of-concern.

5. Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Narrative Overview of Coronavirus Infection: Clinical Signs and Symptoms, Viral Entry and Replication, Treatment Modalities, and Management;Current Topics in Medicinal Chemistry;2024-08

2. You are unmuted: The impact of virtual arrangements on women and old age legislators’ participation during the COVID-19 pandemic;Parliamentary Affairs;2024-06-05

3. Investigation on the Binding Affinity of Five Drug-Like Sulphonamides on SARS-CoV-2 Targets: A computational study;Indian Journal of Chemistry;2024-01-24

4. Reply to Letter to the Editor: “Cardiovascular Events After Coronavirus Disease 2019 Vaccinations: Hypersensitivity Myocarditis After Coronavirus Disease 2019 Vaccines, Diagnostic and Long-term Considerations”;The Anatolian Journal of Cardiology;2024

5. Covid-19: Latin America defies nationalism and circumstance to develop its own vaccines;BMJ;2023-08-07